Journey Medical Corp Announces CFO Promotion and Strategic Update
TipRanksMay 1 16:27 ET
Express News | Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
ReutersMay 1 16:01 ET
There's No Escaping Journey Medical Corporation's (NASDAQ:DERM) Muted Revenues Despite A 30% Share Price Rise
Those holding Journey Medical Corporation (NASDAQ:DERM) shares would be relieved that the share price has rebounded 30% in the last thirty days, but it needs to keep going to repair the recent damage
Simply Wall StApr 13 08:18 ET
Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying
The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
BenzingaMar 28 07:14 ET
VERI, CHEK and MESO Are Among Pre Market Gainers
Seeking AlphaMar 27 08:24 ET
Journey Medical(DERM.US) Director Buys US$30,400 in Common Stock
$Journey Medical(DERM.US)$ Director ROSENWALD LINDSAY A MD purchased 10,000 shares of Common Stock on Mar 25, 2024 at an average price of $3.04 for a total value of $30,400.Source: Announcement What i
moomoo NewsMar 27 07:42 ET
Journey Medical Independent Director Acquires 45% More Stock
Potential Journey Medical Corporation (NASDAQ:DERM) shareholders may wish to note that the Independent Director, Justin Smith, recently bought US$104k worth of stock, paying US$3.47 for each share.
Simply Wall StMar 27 06:29 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersStoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out
BenzingaMar 26 13:31 ET
Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)
Yahoo FinanceMar 25 19:01 ET
Journey Medical(DERM.US) Director Buys US$104.1K in Common Stocks
$Journey Medical(DERM.US)$ Director Smith Justin Adam purchased 30,000 shares of Common Stocks on Mar 22, 2024 at an average price of $3.47 for a total value of $104.1K.Source: Announcement What is st
moomoo NewsMar 25 16:44 ET
Journey Medical(DERM.US) Officer Buys US$34,790 in Common Stocks
$Journey Medical(DERM.US)$ Officer Maraoui Claude purchased 10,000 shares of Common Stocks on Mar 22, 2024 at an average price of $3.479 for a total value of $34,790.Source: Announcement What is state
moomoo NewsMar 25 16:43 ET
Journey Medical(DERM.US) Director Buys US$68,000 in Common Stocks
$Journey Medical(DERM.US)$ Director ROSENWALD LINDSAY A MD purchased 20,000 shares of Common Stocks on Mar 22, 2024 at an average price of $3.4 for a total value of $68,000.Source: Announcement What i
moomoo NewsMar 25 16:43 ET
Journey Medical Full Year 2023 Earnings: EPS Misses Expectations
Yahoo FinanceMar 23 08:52 ET
Express News | Journey Medical Shares Are Trading Lower. The Company Reported Q4 Financial Results
Moomoo 24/7Mar 22 11:39 ET
Canopy Growth, Capricor Therapeutics, GT Biopharma Among Healthcare Movers
Seeking AlphaMar 22 10:00 ET
Q4 2023 Journey Medical Corp Earnings Call
Yahoo FinanceMar 22 06:01 ET
Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript
Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript
Earnings Call TranscriptsMar 21 20:22 ET
Recap: Journey Medical Q4 Earnings
Journey Medical (NASDAQ:DERM) reported its Q4 earnings results on Thursday, March 21, 2024 at 04:01 PM.Here's what investors need to know about the announcement.EarningsJourney Medical beat estimated
BenzingaMar 21 17:05 ET
Journey Medical GAAP EPS of -$0.21 Misses by $0.02, Revenue of $79.18M Beats by $0.21M
Seeking AlphaMar 21 16:04 ET
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. • InflaRx (NASDAQ:IFRX) is projected to
BenzingaMar 21 06:15 ET
No Data
No Data